Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Obstructive Lung Diseases

  Free Subscription


10.09.2018

1 Allergy
1 Am J Respir Cell Mol Biol
3 Am J Respir Crit Care Med
1 Ann Allergy Asthma Immunol
5 Arch Bronconeumol
2 Clin Exp Allergy
3 Eur Respir J
1 J Allergy Clin Immunol
2 JAMA
1 N Engl J Med
1 Pediatrics
5 Respir Med
2 Respir Res
3 Rev Mal Respir


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Allergy

  1. WAHN U, Bachert C, Heinrich J, Richter H, et al
    Real-world benefits of allergen immunotherapy for birch pollen-associated allergic rhinitis and asthma.
    Allergy. 2018 Sep 5. doi: 10.1111/all.13598.
    PubMed     Text format     Abstract available


    Am J Respir Cell Mol Biol

  2. FILLION-BERTRAND G, Dickson RP, Boivin R, Lavoie JP, et al
    Lung Microbiome is Influenced by the Environment and Asthmatic Status in an Equine Model of Asthma.
    Am J Respir Cell Mol Biol. 2018 Sep 5. doi: 10.1165/rcmb.2017-0228.
    PubMed     Text format     Abstract available


    Am J Respir Crit Care Med

  3. SABOGAL PINEROS YS, Bal SM, van de Pol MA, Dierdorp BS, et al
    Anti-IL5 in Mild Asthma Alters Rhinovirus-Induced Macrophage, B Cell and Neutrophil Responses (MATERIAL): A Placebo-Controlled, Double-Blind Study.
    Am J Respir Crit Care Med. 2018 Sep 7. doi: 10.1164/rccm.201803-0461.
    PubMed     Text format     Abstract available

  4. YOON J, Lee SY, Lee SH, Kim EM, et al
    Exposure to Humidifier Disinfectants Increases the Risk of Asthma in Children.
    Am J Respir Crit Care Med. 2018 Sep 7. doi: 10.1164/rccm.201805-0840.
    PubMed     Text format    

  5. SLY PD
    Maternal Asthma, Pregnancy Complications and Offspring Wheeze: Untangling the Web.
    Am J Respir Crit Care Med. 2018 Sep 5. doi: 10.1164/rccm.201808-1584.
    PubMed     Text format    


    Ann Allergy Asthma Immunol

  6. OPPENHEIMER JJ, Borish L
    Update: Asthma Yardstick: Practical recommendations for a sustained step-up in asthma therapy for poorly controlled asthma.
    Ann Allergy Asthma Immunol. 2018 Aug 30. pii: S1081-1206(18)30709.
    PubMed     Text format    


    Arch Bronconeumol

  7. BALOIRA VILLAR A, Palop Cervera M
    Does the Exacerbator Phenotype in Chronic Obstructive Pulmonary Disease Really Exist?
    Arch Bronconeumol. 2018;54:119-120.
    PubMed     Text format    

  8. MORENO-GALARRAGA L, Diaz Munilla L, Herranz Aguirre M, Navarro Jimenez A, et al
    Pediatric Interstitial Lung Disease: an Ongoing Challenge.
    Arch Bronconeumol. 2018;54:169-171.
    PubMed     Text format    

  9. ANZUETO A, Calverley PMA, Mueller A, Metzdorf N, et al
    Demographic Characteristics and Clinical Outcomes in Patients from Latin America Versus the Rest of the World: A TIOSPIR((R)) Post-Hoc Analysis.
    Arch Bronconeumol. 2018;54:140-148.
    PubMed     Text format     Abstract available

  10. MURPHY PB, Hart N
    Home Non-Invasive Ventilation for COPD: How, Who and When?
    Arch Bronconeumol. 2018;54:149-154.
    PubMed     Text format     Abstract available

  11. MENDES MA, Guimaraes M, Neves S, Campainha S, et al
    Combined Pulmonary Fibrosis and Emphysema Versus Idiopathic Pulmonary Fibrosis Versus Emphysema: A Clinical Perspective.
    Arch Bronconeumol. 2018 Sep 3. pii: S0300-2896(18)30313.
    PubMed     Text format    


    Clin Exp Allergy

  12. EGUILUZ-GRACIA I, Malmstrom K, Dheyauldeen SA, Lohi J, et al
    Monocytes accumulate in the airways of children with fatal asthma.
    Clin Exp Allergy. 2018 Sep 5. doi: 10.1111/cea.13265.
    PubMed     Text format     Abstract available

  13. OGAWA H, Azuma M, Tsunematu T, Morimoto Y, et al
    Neutrophils induce smooth muscle hyperplasia via neutrophil elastase-induced FGF-2 in a mouse model of asthma with mixed inflammation.
    Clin Exp Allergy. 2018 Sep 1. doi: 10.1111/cea.13263.
    PubMed     Text format     Abstract available


    Eur Respir J

  14. ARDURA-GARCIA C, Pedersen ESL, Goutaki M
    The limitations of cross-sectional data: perinatal risk factors for asthma.
    Eur Respir J. 2018;52.
    PubMed     Text format    

  15. BOAVENTURA R, Sibila O, Agusti A, Chalmers JD, et al
    Treatable traits in bronchiectasis.
    Eur Respir J. 2018;52.
    PubMed     Text format    

  16. VOLMER T, Effenberger T, Trautner C, Buh R, et al
    Consequences of long-term OCS therapy and its side effects in severe asthma in adults - A focused review of the impact data in the literature.
    Eur Respir J. 2018 Sep 6. pii: 13993003.00703-2018.
    PubMed     Text format     Abstract available


    J Allergy Clin Immunol

  17. MASON P, Frigo AC, Scarpa MC, Maestrelli P, et al
    Cluster Analysis Of Occupational Asthma Due to Isocyanates.
    J Allergy Clin Immunol. 2018 Aug 31. pii: S0091-6749(18)31210.
    PubMed     Text format     Abstract available


    JAMA

  18. SOBIERAJ DM, Baker WL
    SMART in the Management of Patients With Persistent Asthma-Reply.
    JAMA. 2018;320:934.
    PubMed     Text format    

  19. XIA Y, Xia L, Shen H
    SMART in the Management of Patients With Persistent Asthma.
    JAMA. 2018;320:933-934.
    PubMed     Text format    


    N Engl J Med

  20. CAO C, Kong X
    As-Needed Budesonide-Formoterol in Mild Asthma.
    N Engl J Med. 2018;379:897-8.
    PubMed     Text format    


    Pediatrics

  21. NAAR S, Ellis D, Cunningham P, Pennar AL, et al
    Comprehensive Community-Based Intervention and Asthma Outcomes in African American Adolescents.
    Pediatrics. 2018 Sep 5. pii: peds.2017-3737. doi: 10.1542/peds.2017-3737.
    PubMed     Text format     Abstract available


    Respir Med

  22. PAPAIOANNOU AI, Diamant Z, Bakakos P, Loukides S, et al
    Towards precision medicine in severe asthma: Treatment algorithms based on treatable traits.
    Respir Med. 2018;142:15-22.
    PubMed     Text format     Abstract available

  23. PELKONEN MK, Notkola IK, Laatikainen TK, Jousilahti P, et al
    30-year trends in asthma and the trends in relation to hospitalization and mortality.
    Respir Med. 2018;142:29-35.
    PubMed     Text format     Abstract available

  24. CAVALLAZZI R, Jorayeva A, Beatty BL, Antimisiaris D, et al
    Predicting asthma in older adults on the basis of clinical history.
    Respir Med. 2018;142:36-40.
    PubMed     Text format     Abstract available

  25. HEFFLER E, Crimi C, Mancuso S, Campisi R, et al
    Misdiagnosis of asthma and COPD and underuse of spirometry in primary care unselected patients.
    Respir Med. 2018;142:48-52.
    PubMed     Text format     Abstract available

  26. BERTI A, Volcheck GW, Cornec D, Smyth RJ, et al
    Severe/uncontrolled asthma and overall survival in atopic patients with eosinophilic granulomatosis with polyangiitis.
    Respir Med. 2018;142:66-72.
    PubMed     Text format     Abstract available


    Respir Res

  27. WATANABE M, Nakamoto K, Inui T, Sada M, et al
    Serum sST2 levels predict severe exacerbation of asthma.
    Respir Res. 2018;19:169.
    PubMed     Text format     Abstract available

  28. JANSON C, Lisspers K, Stallberg B, Johansson G, et al
    Health care resource utilization and cost for asthma patients regularly treated with oral corticosteroids - a Swedish observational cohort study (PACEHR).
    Respir Res. 2018;19:168.
    PubMed     Text format     Abstract available


    Rev Mal Respir

  29. TAILLE C
    [Metacholine challenge: The D-dimer of asthma diagnosis?]
    Rev Mal Respir. 2018;35:706-707.
    PubMed     Text format    

  30. RABEC C, Gonzalez-Bermejo J, Cuvelier A, Cervantes P, et al
    [Cohort of patients initiated to home ventilation. Observational and prospective study].
    Rev Mal Respir. 2018;35:88-93.
    PubMed     Text format     Abstract available

  31. MESSOUS S, Grissa MH, Beltaief K, Boukef R, et al
    [Bacteriology of acute exacerbations of chronic obstructive pulmonary disease in Tunisia].
    Rev Mal Respir. 2018;35:36-47.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: